Monograph Title | Section | Source Publication Sort descending | Page Number | Errata Post Date | Errata Official Date | Target Errata Print Publication | Target Online Fix Publication | Description |
---|---|---|---|---|---|---|---|---|
DIMENHYDRINATE TABLETS | OTHER COMPONENTS/8-Chlorotheophylline | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | In Analysis: Change CU = nominal concentration of dimenhydrinate in the Sample solution (mg/mL) to: CU = determined concentration of dimenhydrinate in the Sample solution, as obtained in the Assay… Read More |
BACLOFEN INJECTION | SPECIFIC TESTS | USPNF Online | Online | 29-Jul-2022 | 1-Aug-2022 | NA | NA | Change • Osmolality and Osmolarity 〈785〉, Osmolality: 270–320 mOsm/kg to: • Osmolality and Osmolarity 〈785〉 Osmolality: 270–320 mOsm/kg |
TETRACYCLINE HYDROCHLORIDE | ADDITIONAL REQUIREMENTS/Labeling | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | Change Where tetracycline hydrochloride must be sterile or subjected to further processing during the preparation of injectable dosage forms to ensure acceptable levels of bacterial endotoxins, it is so labeled. to: Where Tetracycline Hydrochloride must be… Read More |
MESO-ZEAXANTHIN | CHEMICAL INFORMATION | USPNF Online | Online | 27-Jan-2023 | 1-Jun-2023 | NA | NA | Change (3R,3′S-meso)-Zeaxanthin to: (3R,3′S)-Zeaxanthin |
SUCROSE | IMPURITIES | USPNF Online | Online | 29-Mar-2024 | 1-Apr-2024 | NA | NA | In Sulfite/Analysis/footnote 1: Change Test kit for sulfite determination may be ordered from the following suppliers: Megazyme Ltd. (Product code: K-ETSULPH); R-Biopharm (Enzytec) (Article No.: E6275); BioSenTec/Nzytech (Catalogue No.: AK00071).… Read More |
<1228.1> DRY HEAT DEPYROGENATION | INTRODUCTION | USPNF Online | Online | 23-Feb-2024 | 1-Mar-2024 | NA | NA | Change parental manufacturing to: parenteral manufacturing |
PRAZOSIN HYDROCHLORIDE CAPSULES | ASSAY/Procedure | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | In Analysis: Change CS = concentration of USP Prazosin Hydrochloride RS in the Standard solution (µg/mL) CU = nominal concentration of prazosin in the Sample solution (µg/mL) Mr1… Read More |
DIGOXIN TABLETS | ASSAY/Procedure | USPNF Online | Online | 30-Jun-2023 | 1-Jul-2023 | NA | NA | In Chromatographic system: Change Column: 4.2-mm × 25-cm; 5-μm packing L1 to: Column: 4.6-mm × 25-cm; 5-µm packing L1 |
CRANBERRY FRUIT DRY JUICE | COMPOSITION | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | In Content of Proanthocyanidins/Standard stock solution: Change USP Procyanidin A2 RS to: USP Procyanidin A2 RS AND In Content of Proanthocyanidins/Analysis: Change Use the absorbance recorded for Standard… Read More |
DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE CAPSULES | ADDITIONAL REQUIREMENTS | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In USP Reference Standards 〈11〉/USP Dihydrodutasteride RS: Change N-[2,5-Bis(trifluoromethyl)phenyl]-3-oxo-4-aza-5α-androst-1-ene-17β-carboxamide. to: N-[2,5-Bis(trifluoromethyl)phenyl]-3-oxo-4-aza-5α-androstane-17β-carboxamide. |
RIFABUTIN | CHEMICAL INFORMATION | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | Change 847.00 to: 847.02 AND Change (9S,12E,14S,15R,16S,17R,18R,19R,20S,21S,22E,24Z)-6,16,18,20-Tetrahydroxy-1′-isobutyl-14-methoxy-7,9,15,17,19,21,25-heptamethylspiro[9,4-(epoxypentadeca[1,11,13]… Read More |
MELOXICAM ORAL SUSPENSION | PERFORMANCE TESTS/Dissolution <711> | USPNF Online | Online | 29-Jul-2022 | 1-Aug-2022 | NA | NA | In Analysis: Change WU = weight of the Oral Suspension taken (mg) to: WU = weight of the Oral Suspension taken (g) |
SITAGLIPTIN PHOSPHATE | CHEMICAL INFORMATION | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | Change 523.32 to: 523.33 AND Change (3R)-3-Amino-1-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl-4-(2,4,5-trifluorophenyl)butan-1-one phosphate monohydrate to: (3R)-3-Amino-1-[3-(trifluoromethyl)-… Read More |
MESO-ZEAXANTHIN | IDENTIFICATION/C. | USPNF Online | Online | 27-Jan-2023 | 1-Jun-2023 | NA | NA | Change (3R,3′S-meso)-zeaxanthin to: (3R,3′S)-zeaxanthin |
ENSULIZOLE | IDENTIFICATION | USPNF Online | Online | 29-Mar-2024 | 1-Apr-2024 | NA | NA | In B.: Change The retention time of the major peak of the Sample solution exhibits maxima and minima at the same wavelengths as those of the Standard solution, as obtained in the Assay. to: The retention time of the major… Read More |
PRAZOSIN HYDROCHLORIDE CAPSULES | PERFORMANCE TESTS/Dissolution 〈711〉 | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | In Test 2/Analysis: Change CS = concentration of USP Prazosin Hydrochloride RS in the Standard solution (µg/mL) to: CS = concentration of USP Prazosin Hydrochloride RS in the Standard… Read More |
SITAGLIPTIN PHOSPHATE | IMPURITIES/Organic Impurities | USPNF Online | Online | 30-Jun-2023 | 1-Jul-2023 | NA | NA | In Analysis: Change CS = concentration of USP Sitagliptin Phosphate in the Standard solution (mg/mL) to: CS = concentration of USP Sitagliptin Phosphate RS in the Standard solution (mg/mL) |
CRANBERRY FRUIT DRY JUICE | ADDITIONAL REQUIREMENTS | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | In USP Reference Standards 〈11〉: Change USP Procyanidin A2 RS to: USP Procyanidin A2 RS |
NORFLURANE | IMPURITIES | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In Organic Impurities/Table 2: Change Line No. to: Peak Elution Order AND In Halides/Figure 1: Add label Flow Meter |
APREPITANT CAPSULES | PERFORMANCE TESTS/Dissolution <711> | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | Change Test 1 Dilute 1 mL of phosphoric acid with water to 1 L. to: Test 1 AND Change Dilute phosphoric acid: to: Dilute phosphoric acid: Dilute 1 mL of phosphoric acid with water to 1 L. |
<871> SUTURES--NEEDLE ATTACHMENT | PROCEDURE | USPNF Online | Online | 29-Jul-2022 | 1-Aug-2022 | NA | NA | In Removable Needle Attachment: Change For USP sizes 5-0 through 2-0, to: For USP sizes 5-0 through 2, |
DOXORUBICIN HYDROCHLORIDE FOR INJECTION | ASSAY/Procedure | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In Analysis: Change P = potency of doxorubicin in USP Doxorubicin Hydrochloride RS (µg/mg) to: P = potency of doxorubicin hydrochloride in USP Doxorubicin Hydrochloride RS (µg/mg) |
MESO-ZEAXANTHIN | COMPOSITION/Stereoisomeric Composition | USPNF Online | Online | 27-Jan-2023 | 1-Jun-2023 | NA | NA | In System suitability: Change [Note—The approximate relative retention times for (3S,3′S)-zeaxanthin, (3R,3′S-meso)-zeaxanthin, (3R,3′R)-zeaxanthin, and (3R,3′R,6′R)-lutein are 0.94… Read More |
RIVASTIGMINE TARTRATE | IMPURITIES | USPNF Online | Online | 26-Apr-2024 | 1-May-2024 | NA | NA | In Organic Impurities/Procedure 1/Impurity Table 1/footnote d: Change 3-Nitrophenyl ethyl(methyl)carbamate. to: 4-Nitrophenyl ethyl(methyl)carbamate. |
CALCIUM LACTATE | CHEMICAL INFORMATION | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | Change Calcium lactate (1:2) hydrate to: Calcium lactate hydrate AND Change Calcium lactate (1:2) pentahydrate to: Calcium lactate pentahydrate |
ATORVASTATIN CALCIUM TABLETS | ASSAY/Procedure | USPNF Online | Online | 30-Jun-2023 | 1-Jul-2023 | NA | NA | In Analysis: Change Mr1 = molecular weight of atorvastatin, 558.64 Mr2 = molecular weight of atorvastatin calcium, 1155.34 to: Mr1 = molecular weight of atorvastatin, 558.65 M… Read More |
FOSAMPRENAVIR CALCIUM TABLETS | PERFORMANCE TESTS | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | In Dissolution 〈711〉/Medium: Change 26.7 g/L of sodium acetate trihydrate in water. Add 133 mL of glacial acetic acid to this solution, and then dilute with water to 10 L; 900 mL. to: 0.02 M sodium acetate buffer, pH 3.5, prepared as follows.… Read More |
OLMESARTAN MEDOXOMIL TABLETS | PERFORMANCE TESTS | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In Dissolution 〈711〉/Test 5/Apparatus 2: Change 50 rpm. Use peak vessels. to: 50 rpm. Use apex vessels. |
<565> BOTANICAL EXTRACTS | PREPARATIONS | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | In General Pharmacopeial Requirements/Pesticide Residues: Change where L is the limit in the original article as listed in Table 4 (see Pesticide Residue Analysis under Articles of Botanical Origin <561>)… Read More |
POWDERED FORSKOHLII EXTRACT | COMPOSITION/Content of Forskolin | USPNF Online | Online | 29-Jul-2022 | 1-Aug-2022 | NA | NA | In Chromatographic system: Change Column: 4.6-mm × 25-cm; 5-µm, 100 Å to: Column: 4.6-mm × 25-cm; 5-µm, 100 Å; packing L1 |
DOXORUBICIN HYDROCHLORIDE FOR INJECTION | IMPURITIES/Organic Impurities | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In Analysis: Change P = potency of doxorubicin in USP Doxorubicin Hydrochloride RS (µg/mg) to: P = potency of doxorubicin hydrochloride in USP Doxorubicin Hydrochloride RS (µg/mg) |
MESO-ZEAXANTHIN | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 27-Jan-2023 | 1-Jun-2023 | NA | NA | In USP meso-Zeaxanthin RS: Change (3R,3′S-meso)-Zeaxanthin. to: (3R,3′S)-Zeaxanthin. |
RIVASTIGMINE TARTRATE | ADDITIONAL REQUIREMENTS | USPNF Online | Online | 26-Apr-2024 | 1-May-2024 | NA | NA | In USP Reference Standards 〈11〉: Change USP Rivastigmine Tartrate R-Isomer RS to: USP Rivastigmine Tartrate R-Isomer RS (R)-3-[1-(Dimethylamino)ethyl]phenyl ethylmethylcarbamate, hydrogen tartrate. C14H22N2… Read More |
LEVORPHANOL TARTRATE TABLETS | PERFORMANCE TESTS/Uniformity of Dosage Units 〈905〉 | USPNF Online | Online | 31-Mar-2023 | 1-Aug-2023 | NA | NA | In Sample solution: Change Nominally about 80 ug/mL of levorphanol tartrate in Diluent prepared as follows. to: Nominally about 80 µg/mL of levorphanol tartrate in Diluent prepared as follows. |
ATORVASTATIN CALCIUM TABLETS | PERFORMANCE TESTS/Dissolution 〈711〉 | USPNF Online | Online | 30-Jun-2023 | 1-Jul-2023 | NA | NA | In Test 1, Test 3, Test 4, Test 5, and Test 6/Analysis: Change Mr1 = molecular weight of atorvastatin, 558.64 Mr2 = molecular weight of atorvastatin calcium, 1155.34 to: … Read More |
OCTOCRYLENE | IDENTIFICATION | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | In A./Acceptance criteria: Change NMT 3.0%, calculated on the as-is basis to: Absorptivities, calculated on the as-is basis, do not differ by more than 3.0%. |
PANTOPRAZOLE SODIUM DELAYED-RELEASE TABLETS | PERFORMANCE TESTS | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In Dissolution 〈711〉/Test 2/Acid stage: Change Acid stage standard solution: (L/10) mg/mL of USP Pantoprazole Sodium RS from the Standard stock solution in Acid stage medium, where L is the label claim… Read More |
NANDROLONE DECANOATE | ASSAY/Procedure | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | In Analysis: Change Calculate the percentage of Nandrolone Decanoate (C28H44O3) in the portion of Nandrolone Decanoate taken: to: Calculate the percentage of nandrolone decanoate (C28H44O… Read More |
FORSKOHLII | COMPOSITION/Content of Forskolin | USPNF Online | Online | 29-Jul-2022 | 1-Aug-2022 | NA | NA | In Chromatographic system: Change Column: 4.6-mm × 25-cm; 5-µm, 100 Å to: Column: 4.6-mm × 25-cm; 5-µm, 100 Å; packing L1 |
DOXORUBICIN HYDROCHLORIDE INJECTION | ASSAY/Procedure | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In Analysis: Change P = potency of doxorubicin in USP Doxorubicin Hydrochloride RS (µg/mg) to: P = potency of doxorubicin hydrochloride in USP Doxorubicin Hydrochloride RS (µg/mg) |
AZTEC MARIGOLD ZEAXANTHIN EXTRACT | IDENTIFICATION/C. | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | Change (3R,3′S meso)-zeaxanthin to: (3R,3′S)-zeaxanthin |
BROMPHENIRAMINE MALEATE | SPECIFIC TESTS | USPNF Online | Online | 26-Apr-2024 | 1-May-2024 | NA | NA | Change Optical Rotation 〈781〉 to: Optical Rotation, Angular Rotation 〈781A〉 |
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL TABLETS | PERFORMANCE TESTS/Dissolution 〈711〉 | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | In Test 2/Analysis: Change CS = concentration of USP Norethindrone Acetate RS (mg/mL) or USP Ethinyl Estradiol RS (ug/mL) in the Standard solution to: CS = concentration of USP Norethindrone Acetate… Read More |
ATORVASTATIN CALCIUM TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards 〈11〉 | USPNF Online | Online | 30-Jun-2023 | 1-Jul-2023 | NA | NA | In USP Atorvastatin Related Compound B RS: Change 1155.34 to: 1155.36 |
ZIPRASIDONE CAPSULES | ASSAY | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | In Procedure/Analysis: Change 449.40 to: 449.39 |
SODIUM SALICYLATE | ADDITIONAL REQUIREMENTS | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In USP Reference Standards 〈11〉: Add USP Phenol RS |
AZITHROMYCIN FOR ORAL SUSPENSION | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | In USP Azithromycin Related Compound F RS: Change 762.97 to: 762.98 AND In USP Desosaminylazithromycin RS: Change 590.79 to: 590.80 |
POWDERED FORSKOHLII | COMPOSITION/Content of Forskolin | USPNF Online | Online | 29-Jul-2022 | 1-Aug-2022 | NA | NA | In Chromatographic system: Change Column: 4.6-mm × 25-cm; 5-µm, 100 Å to: Column: 4.6-mm × 25-cm; 5-µm, 100 Å; packing L1 |
AZTEC MARIGOLD ZEAXANTHIN EXTRACT | COMPOSITION/Procedure 4: Stereoisomeric Composition | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | In System suitability/Suitability requirements/Resolution: Change (3R,3′S meso)-zeaxanthin to: (3R,3′S)-zeaxanthin AND In Analysis: Change (3R,3′S … Read More |
DAPSONE TABLETS | PERFORMANCE TESTS | USPNF Online | Online | 26-Apr-2024 | 1-May-2024 | NA | NA | In Dissolution 〈711〉/Standard solution: Change USP Dapsone RS of a known concentration in Medium to: (L/1000) mg/mL of USP Dapsone RS in Medium, where L is the label claim in mg/Tablet. Transfer a portion of this… Read More |